Gotham Asset Management LLC Acquires 18,209 Shares of Teleflex Incorporated (NYSE:TFX)

Gotham Asset Management LLC boosted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 312.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 24,038 shares of the medical technology company's stock after purchasing an additional 18,209 shares during the quarter. Gotham Asset Management LLC owned about 0.05% of Teleflex worth $4,278,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Barclays PLC raised its position in shares of Teleflex by 1.6% in the 3rd quarter. Barclays PLC now owns 89,907 shares of the medical technology company's stock valued at $22,233,000 after buying an additional 1,426 shares in the last quarter. Franklin Resources Inc. raised its position in Teleflex by 64.3% during the third quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company's stock valued at $2,298,000 after purchasing an additional 3,790 shares in the last quarter. Principal Financial Group Inc. raised its position in Teleflex by 2.7% during the third quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company's stock valued at $19,887,000 after purchasing an additional 2,086 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in Teleflex by 4.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company's stock worth $588,000 after purchasing an additional 128 shares during the last quarter. Finally, Czech National Bank boosted its holdings in shares of Teleflex by 4.9% in the 4th quarter. Czech National Bank now owns 10,070 shares of the medical technology company's stock valued at $1,792,000 after purchasing an additional 472 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Trading Down 0.2%

Shares of Teleflex stock traded down $0.26 during trading on Tuesday, hitting $127.53. The company's stock had a trading volume of 57,606 shares, compared to its average volume of 635,427. The stock has a market cap of $5.64 billion, a price-to-earnings ratio of 25.37, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. Teleflex Incorporated has a 52 week low of $120.06 and a 52 week high of $249.91. The stock has a 50-day moving average price of $132.68 and a two-hundred day moving average price of $161.79. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The company had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm's quarterly revenue was down 5.0% on a year-over-year basis. During the same period in the previous year, the firm earned $3.21 earnings per share. Equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a $0.34 dividend. The ex-dividend date is Tuesday, May 20th. This represents a $1.36 annualized dividend and a yield of 1.07%. Teleflex's payout ratio is 42.90%.

Wall Street Analyst Weigh In

TFX has been the subject of several recent analyst reports. Morgan Stanley dropped their price objective on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Monday, May 5th. Raymond James lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Truist Financial dropped their price objective on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. Royal Bank of Canada cut their target price on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research report on Friday, May 2nd. Finally, Bank of America downgraded shares of Teleflex from a "neutral" rating to an "underperform" rating and lowered their price target for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $164.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.